Clinical Trial Update: Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant nano-crystalline megestrol acetate for high-risk head and neck squamous cell carcinoma after surgery; the study status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nano-crystalline Megestrol Acetate (Megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors | Phase 3 | Status: NOT_YET_RECRUITING